Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Total Assets of $26.73 million for fiscal year 2024.
NORTHWEST BIOTHERAPEUTICS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $26.73M | -4.1% |
| 2023 | $27.86M | -11.0% |
| 2022 | $31.32M | -22.0% |
| 2021 | $40.16M | +22.1% |
| 2020 | $32.90M | +209.1% |
| 2019 | $10.64M | -56.9% |
| 2018 | $24.67M | -49.6% |
| 2017 | $48.91M | -7.6% |
| 2016 | $52.91M | -25.3% |
| 2015 | $70.80M | +25.4% |
| 2014 | $56.46M | +200.6% |
| 2013 | $18.78M | +148.1% |
| 2012 | $7.57M | +3470.8% |
| 2011 | $212.0K | -27.9% |
| 2010 | $294.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.61M | +4.4% | +3.6% |
| June 30, 2025 | $29.55M | +4.7% | +7.4% |
| March 31, 2025 | $27.50M | -3.7% | +2.9% |
| December 31, 2024 | $26.73M | -4.1% | -8.8% |
| September 30, 2024 | $29.32M | -6.9% | +3.9% |
| June 30, 2024 | $28.23M | -0.7% | -1.2% |
| March 31, 2024 | $28.57M | -13.1% | +2.5% |
| December 31, 2023 | $27.86M | -11.0% | -11.5% |
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -4.1% in Total Assets compared to the prior fiscal year.
- Over the 2010–2024 period, NORTHWEST BIOTHERAPEUTICS INC’s total assets has grown by 8991.2% (from $294.0 thousand to $26.73 million).
- The most recent figure is from NORTHWEST BIOTHERAPEUTICS INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: